Article
The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis.
International journal of clinical oncology - 1 Jun 2020
Liu Jia-Yong, Zhu Bao-Rang, Wang Yu-Dong, Sun Xin
Abstract excerpt
OBJECTIVE: The aim of this study was to investigate the efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis. METHODS: Designed as a retrospective study, a total of 105 metastatic osteosarcoma patients who progressed after standard therapy were included in this study. The metastatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.